[HTML][HTML] Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax …

OKM Djigo, MA Bollahi, M Hasni Ebou… - PLoS …, 2019 - journals.plos.org
Background Primaquine is recommended by the World Health Organization (WHO) for
radical treatment of Plasmodium vivax malaria. This drug is known to provoke acute …

Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria …

OKM Djigo, MA Bollahi, MH Ebou… - PloS …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Primaquine is recommended by the World Health Organization (WHO) for
radical treatment of Plasmodium vivax malaria. This drug is known to provoke acute …

Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria …

OKM Djigo, MA Bollahi, OA Salem, R Tahar, H Bogreau… - Plos one, 2019 - europepmc.org
Background Primaquine is recommended by the World Health Organization (WHO) for
radical treatment of Plasmodium vivax malaria. This drug is known to provoke acute …

Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria …

MA Bollahi, M Hasni Ebou… - PLoS …, 2019 - search.ebscohost.com
Background: Primaquine is recommended by the World Health Organization (WHO) for
radical treatment of Plasmodium vivax malaria. This drug is known to provoke acute …

[PDF][PDF] Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax …

D OkM, MA Bollahi, M Hasni Ebou, OA Salem, R Tahar… - PLoS ONE, 2019 - core.ac.uk
Background Primaquine is recommended by the World Health Organization (WHO) for
radical treatment of Plasmodium vivax malaria. This drug is known to provoke acute …

Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria …

D OkM, MA Bollahi, M Hasni Ebou, OA Salem… - PLoS …, 2019 - documentation.ird.fr
Background Primaquine is recommended by the World Health Organization (WHO) for
radical treatment of Plasmodium vivax malaria. This drug is known to provoke acute …

[HTML][HTML] Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax …

MA Bollahi, MH Ebou, MSOA Salem, R Tahar… - PLoS ONE, 2019 - ncbi.nlm.nih.gov
Background Primaquine is recommended by the World Health Organization (WHO) for
radical treatment of Plasmodium vivax malaria. This drug is known to provoke acute …

[PDF][PDF] Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax …

D OkM, MA Bollahi, M Hasni Ebou, OA Salem… - PLoS ONE, 2019 - researchgate.net
Background Primaquine is recommended by the World Health Organization (WHO) for
radical treatment of Plasmodium vivax malaria. This drug is known to provoke acute …

[引用][C] Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax …

MA Bollahi, M Hasni Ebou… - PLoS …, 2019 - ui.adsabs.harvard.edu
Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid
diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic …

Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax …

OKM Djigo, MA Bollahi, MH Ebou, M Salem, R Tahar… - 2019 - cabidigitallibrary.org
Background: Primaquine is recommended by the World Health Organization (WHO) for
radical treatment of Plasmodium vivax malaria. This drug is known to provoke acute …